Compare · AVNS vs SNN
AVNS vs SNN
Side-by-side comparison of Avanos Medical Inc. (AVNS) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AVNS and SNN operate in Industrial Specialties (Health Care), so they compete in similar markets.
- SNN is the larger of the two at $12.41B, about 10.6x AVNS ($1.17B).
- Over the past year, AVNS is up 116.4% and SNN is down 21.7% - AVNS leads by 138.0 points.
- SNN has been more active in the news (14 items in the past 4 weeks vs 1 for AVNS).
- SNN has more recent analyst coverage (25 ratings vs 7 for AVNS).
- Company
- Avanos Medical Inc.
- Smith & Nephew SNATS Inc.
- Price
- $24.99+0.04%
- $29.21-1.43%
- Market cap
- $1.17B
- $12.41B
- 1M return
- +0.32%
- -6.18%
- 1Y return
- +116.36%
- -21.68%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2014
- News (4w)
- 1
- 14
- Recent ratings
- 7
- 25
Avanos Medical Inc.
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest AVNS
- SEC Form 15-12G filed by Avanos Medical Inc.
- SEC Form S-8 POS filed by Avanos Medical Inc.
- Avanos Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- SVP, Operations Delgado Sigfrido returned $2,765,675 worth of shares to the company (110,627 units at $25.00) and was granted 54,886 shares, closing all direct ownership in the company (SEC Form 4) (tax liability)
- SVP, Chief Financial Officer Galovan Scott Michael returned $5,792,925 worth of shares to the company (231,717 units at $25.00) and was granted 96,121 shares, closing all direct ownership in the company (SEC Form 4) to satisfy tax liability
- Chief Executive Officer Pacitti David returned $19,173,100 worth of shares to the company (766,924 units at $25.00) and was granted 444,730 shares, closing all direct ownership in the company (SEC Form 4) (tax liability)
- Director Shimer Julie Ann returned $1,252,250 worth of shares to the company (50,090 units at $25.00), closing all direct ownership in the company (SEC Form 4) to cover taxes
- Director Oleary Patrick J returned $1,366,000 worth of shares to the company (54,640 units at $25.00), closing all direct ownership in the company (SEC Form 4) (for tax liability)
- Director Franchini Indrani Lall returned $120,425 worth of shares to the company (4,817 units at $25.00), closing all direct ownership in the company (SEC Form 4) (for withholding tax)
- Director Egbuonu-Davis Lisa returned $345,275 worth of shares to the company (13,811 units at $25.00), closing all direct ownership in the company (SEC Form 4) (for tax liability)
Latest SNN
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
- Smith+Nephew’s new FLOW FLEXTEND™ COBLATION™ Wand improves access¹* and resection efficiency²** for complex hip procedures vs. fixed-angle options
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith & Nephew downgraded by Analyst
- Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week